Nonspecific Binding-Fundamental Concepts and Consequences for Biosensing Applications.
Andreas Frutiger1, Alexander Tanno1, Stephanie Hwu1
1Laboratory of Biosensors and Bioelectronics, Institute for Biomedical Engineering, ETH Zürich, Zürich CH-8092, Switzerland.
Nonspecific binding is a major challenge in biosensor technology. This review explores its history, theoretical models, and practical solutions for both in vitro and in vivo applications.
Area of Science:
- Biomolecular interactions
- Biosensor technology
- Molecular recognition
Background:
- Distinguishing specific from nonspecific binding is crucial for biosensor accuracy.
- Nonspecific binding remains a significant bottleneck in biosensor development.
- A fundamental understanding of nonspecific binding is lacking, leading to ongoing debate.
Purpose of the Study:
- To review the evolution of the concept of nonspecific binding over five decades.
- To provide classification frameworks for biomolecular interactions.
- To introduce theoretical models for biosensor performance prediction and optimization.
Main Methods:
- Thermodynamic, intermolecular, and structural perspectives on binding.
- Review of theoretical models for biosensor behavior in physiological environments.
- Discussion of practical approaches to mitigate nonspecific binding.
Main Results:
- Classification frameworks for biomolecular interactions based on binding perspectives.
- Theoretical models to predict biosensor detection limits and optimize performance.
- Overview of strategies to address and utilize nonspecific binding.
Conclusions:
- Understanding nonspecific binding is key to advancing biosensor technology.
- Theoretical models aid in predicting and optimizing biosensor performance.
- Practical solutions exist for in vitro applications, with potential for in vivo systems.
More Related Videos
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
15:27Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
